Ex Vivo News and Research

RSS
Article evaluating StemEx therapy for leukemia and lymphoma to be published

Article evaluating StemEx therapy for leukemia and lymphoma to be published

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

Covidien launches V-Loc absorbable wound closure device

Covidien launches V-Loc absorbable wound closure device

NHLBI awards $16.7 million to develop new clinical strategies in stem cell therapy

NHLBI awards $16.7 million to develop new clinical strategies in stem cell therapy

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

NCI awards BioMarker Strategies a SBIR contract to develop its SnapPath live-tumor-cell testing system

Gamida Cell publishes article evaluating Stemex for leukemia and lymphoma

Gamida Cell publishes article evaluating Stemex for leukemia and lymphoma

National Institutes of Health awards $16.8 million grant to Hutchinson Center/UW group

National Institutes of Health awards $16.8 million grant to Hutchinson Center/UW group

Importance of residual thymopoiesis in aged adults

Importance of residual thymopoiesis in aged adults

Clinical study results of DAS181 against H1N1 influenza presented

Clinical study results of DAS181 against H1N1 influenza presented

New method found for the diagnosis of cartilage disease

New method found for the diagnosis of cartilage disease

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

Antibiotics could treat cystic fibrosis, other genetic diseases

Antibiotics could treat cystic fibrosis, other genetic diseases

World-first technique used to repair an injured donor lung

World-first technique used to repair an injured donor lung

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

New method improves immunotherapy

New method improves immunotherapy

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

New approach to treating vision loss caused by type 1 Usher syndrome

New approach to treating vision loss caused by type 1 Usher syndrome